Help improve vaccine use in older adults
Treatments studied
This study looks at how to increase preventive care—especially flu and pneumonia vaccines—in people age 70 and older. It may help you get up to date on vaccines that can lower the risk of serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years old or older and live in the community (not in a long-term care facility).
- In the past 3 years (2020–2022), you did not consistently get the seasonal flu shot.
- Either you have never had a pneumonia vaccine, or you have not had the kind listed in the study.
- You can speak and communicate in Cantonese or Mandarin and you can read Chinese.
- You do not have memory problems or mental health issues that would stop you from understanding or participating.
- You do not have medical reasons you cannot safely receive vaccines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests community-based health education in Hong Kong to help people recognize COVID-19 early, get vaccinated, and use everyday self-protective steps. It may help participants learn practical ways to lower their risk and respond sooner if symptoms appear.
This trial tests a community-based “health-social partnership” program designed to help older adults manage their health and self-care better. You may be a good match if you can think and communicate clearly and live in the program’s local service area.
This study looks at why older adults in Hong Kong join or do not join District Health Centres. It may help improve health services for people like you.
This study explores whether using ChatGPT can help encourage older adults in Hong Kong to get their seasonal flu shot. If you join, you will interact with ChatGPT to see if it makes getting vaccinated easier for you.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This trial tests whether a flu vaccine with an extra ingredient (called an adjuvant) is safer and works better for older Asian adults with chronic health conditions than a standard flu vaccine. It aims to provide better protection against the flu for people like you.
Hear when a new Health Communication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.